Modeling the pharmacodynamics of nandrolone doping drug and implications for anti‐doping testing

Özge Sahin, Feyyaz Senturk, Yaman Barlas and Hakan Yasarcan

System Dynamics Review, 2020, vol. 36, issue 4, 467-496

Abstract: We model the pathways of nandrolone in the body, an anabolic steroid widely used as a performance enhancing drug (PED). The model generates the dynamics of nandrolone and its metabolites. PED tests check for the presence of a primary metabolite of nandrolone, 19‐NA in urine. To cheat in these tests, PED users typically use inhibitors that reduce the urinary concentration of 19‐NA. One such inhibitor is finasteride. Finasteride’s main effect in the body is the inhibition of reductase enzymes that turn nandrolone into its metabolite 19‐NA. To capture this effect, we include structures for finasteride and reductase enzymes in the model. The model is tested by fundamental structure validity tests. We also show that the model behavior is consistent with experimental data in the literature. We finally investigate the potential ways by which the drug users may cheat in PED tests and make suggestions for improved testing as counter‐measures. © 2021 System Dynamics Society

Date: 2020
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://doi.org/10.1002/sdr.1672

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:bla:sysdyn:v:36:y:2020:i:4:p:467-496

Ordering information: This journal article can be ordered from
http://www.blackwell ... bs.asp?ref=0883-7066

Access Statistics for this article

More articles in System Dynamics Review from System Dynamics Society
Bibliographic data for series maintained by Wiley Content Delivery ().